Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the Risk and Prevention Study.

Marzona I, Avanzini F, Lucisano G, Tettamanti M, Baviera M, Nicolucci A, Roncaglioni MC; Risk & Prevention Collaborative Group.

Acta Diabetol. 2017 Feb;54(2):123-131. doi: 10.1007/s00592-016-0899-0. Epub 2016 Oct 7.

PMID:
27718051
2.

n-3 fatty acids in patients with multiple cardiovascular risk factors.

Risk and Prevention Study Collaborative Group, Roncaglioni MC, Tombesi M, Avanzini F, Barlera S, Caimi V, Longoni P, Marzona I, Milani V, Silletta MG, Tognoni G, Marchioli R.

N Engl J Med. 2013 May 9;368(19):1800-8. doi: 10.1056/NEJMoa1205409. Erratum in: N Engl J Med. 2013 May 30;368(22):2146.

3.

Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect.

Cairoli E, Rebella M, Danese N, Garra V, Borba EF.

Lupus. 2012 Oct;21(11):1178-82. doi: 10.1177/0961203312450084. Epub 2012 May 28.

PMID:
22641182
4.

Extensive calcinosis in juvenile dermatomyositis.

Cairoli E, Garra V, Bruzzone MJ, Gambini JP.

Acta Reumatol Port. 2011 Apr-Jun;36(2):180-1. No abstract available.

6.

[Sildenafil in the treatment of digital ulcers in patients with systemic sclerosis].

Cairoli E, Garra V, Martínez M.

Actas Dermosifiliogr. 2009 Nov;100(9):830-2. Spanish. No abstract available.

PMID:
19889312

Supplemental Content

Loading ...
Support Center